Judge rules against As­traZeneca in suit over IRA price ne­go­ti­a­tions

A fed­er­al judge in Delaware on Fri­day ruled in fa­vor of the Biden ad­min­is­tra­tion in a case brought by As­traZeneca seek­ing to over­turn parts of the drug price ne­go­ti­a­tions es­tab­lished by the In­fla­tion Re­duc­tion Act.

The opin­ion makes clear that As­traZeneca’s con­sti­tu­tion­al chal­lenge against the IRA should not move for­ward be­cause the com­pa­ny “has no le­git­i­mate claim of en­ti­tle­ment to sell its drugs to the Gov­ern­ment at any price oth­er than what the Gov­ern­ment is will­ing to pay,” mean­ing “its due process claim fails as a mat­ter of law.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER